Modern Healthcare Technology Holdings Limited

SEHK:919 Voorraadrapport

Marktkapitalisatie: HK$83.2m

Modern Healthcare Technology Holdings Beheer

Beheer criteriumcontroles 2/4

De CEO Modern Healthcare Technology Holdings is Joyce Tsang, benoemd in Apr2010, heeft een ambtstermijn van 14.58 jaar. De totale jaarlijkse vergoeding van { bedraagt HK$ 15.79M, bestaande uit 99.5% salaris en 0.5% bonussen, inclusief aandelen en opties van het bedrijf. bezit rechtstreeks 74.88% van de aandelen van het bedrijf, ter waarde HK$ 62.31M. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 12.8 jaar en 14.9 jaar.

Belangrijke informatie

Joyce Tsang

Algemeen directeur

HK$15.8m

Totale compensatie

Percentage CEO-salaris99.5%
Dienstverband CEO14.6yrs
Eigendom CEO74.9%
Management gemiddelde ambtstermijn12.8yrs
Gemiddelde ambtstermijn bestuur14.9yrs

Recente managementupdates

It Looks Like Modern Healthcare Technology Holdings Limited's (HKG:919) CEO May Expect Their Salary To Be Put Under The Microscope

Aug 21
It Looks Like Modern Healthcare Technology Holdings Limited's (HKG:919) CEO May Expect Their Salary To Be Put Under The Microscope

Recent updates

A Look At The Fair Value Of Modern Healthcare Technology Holdings Limited (HKG:919)

Oct 04
A Look At The Fair Value Of Modern Healthcare Technology Holdings Limited (HKG:919)

Modern Healthcare Technology Holdings Limited (HKG:919) Not Doing Enough For Some Investors As Its Shares Slump 27%

Oct 04
Modern Healthcare Technology Holdings Limited (HKG:919) Not Doing Enough For Some Investors As Its Shares Slump 27%

It Looks Like Modern Healthcare Technology Holdings Limited's (HKG:919) CEO May Expect Their Salary To Be Put Under The Microscope

Aug 21
It Looks Like Modern Healthcare Technology Holdings Limited's (HKG:919) CEO May Expect Their Salary To Be Put Under The Microscope

Investors Aren't Buying Modern Healthcare Technology Holdings Limited's (HKG:919) Revenues

Apr 08
Investors Aren't Buying Modern Healthcare Technology Holdings Limited's (HKG:919) Revenues

Investors Don't See Light At End Of Modern Healthcare Technology Holdings Limited's (HKG:919) Tunnel And Push Stock Down 29%

Dec 18
Investors Don't See Light At End Of Modern Healthcare Technology Holdings Limited's (HKG:919) Tunnel And Push Stock Down 29%

Modern Healthcare Technology Holdings (HKG:919) Is Experiencing Growth In Returns On Capital

Jun 30
Modern Healthcare Technology Holdings (HKG:919) Is Experiencing Growth In Returns On Capital

Be Wary Of Modern Healthcare Technology Holdings (HKG:919) And Its Returns On Capital

May 04
Be Wary Of Modern Healthcare Technology Holdings (HKG:919) And Its Returns On Capital

Modern Healthcare Technology Holdings (HKG:919) Is Reinvesting At Lower Rates Of Return

Jan 31
Modern Healthcare Technology Holdings (HKG:919) Is Reinvesting At Lower Rates Of Return

Modern Healthcare Technology Holdings Limited's (HKG:919) Popularity With Investors Under Threat As Stock Sinks 29%

Dec 02
Modern Healthcare Technology Holdings Limited's (HKG:919) Popularity With Investors Under Threat As Stock Sinks 29%

Shareholders Will Probably Hold Off On Increasing Modern Healthcare Technology Holdings Limited's (HKG:919) CEO Compensation For The Time Being

Aug 20
Shareholders Will Probably Hold Off On Increasing Modern Healthcare Technology Holdings Limited's (HKG:919) CEO Compensation For The Time Being

Should You Be Adding Modern Healthcare Technology Holdings (HKG:919) To Your Watchlist Today?

Apr 11
Should You Be Adding Modern Healthcare Technology Holdings (HKG:919) To Your Watchlist Today?

Does Modern Healthcare Technology Holdings' (HKG:919) CEO Salary Compare Well With Industry Peers?

Feb 16
Does Modern Healthcare Technology Holdings' (HKG:919) CEO Salary Compare Well With Industry Peers?

Are Modern Healthcare Technology Holdings's (HKG:919) Statutory Earnings A Good Guide To Its Underlying Profitability?

Jan 13
Are Modern Healthcare Technology Holdings's (HKG:919) Statutory Earnings A Good Guide To Its Underlying Profitability?

We're Watching These Trends At Modern Healthcare Technology Holdings (HKG:919)

Dec 01
We're Watching These Trends At Modern Healthcare Technology Holdings (HKG:919)

Analyse CEO-vergoeding

Hoe is Joyce Tsang's beloning veranderd ten opzichte van Modern Healthcare Technology Holdings's winst?
DatumTotale vergoedingSalarisBedrijfswinsten
Mar 31 2024HK$16mHK$16m

-HK$10m

Dec 31 2023n/an/a

-HK$50m

Sep 30 2023n/an/a

-HK$90m

Jun 30 2023n/an/a

-HK$55m

Mar 31 2023HK$13mHK$13m

-HK$21m

Dec 31 2022n/an/a

-HK$3m

Sep 30 2022n/an/a

HK$14m

Jun 30 2022n/an/a

-HK$28m

Mar 31 2022HK$13mHK$13m

-HK$69m

Dec 31 2021n/an/a

-HK$25m

Sep 30 2021n/an/a

HK$18m

Jun 30 2021n/an/a

HK$72m

Mar 31 2021HK$11mHK$11m

HK$126m

Dec 31 2020n/an/a

HK$77m

Sep 30 2020n/an/a

HK$29m

Jun 30 2020n/an/a

-HK$1m

Mar 31 2020HK$10mHK$10m

-HK$32m

Dec 31 2019n/an/a

-HK$15m

Sep 30 2019n/an/a

HK$3m

Jun 30 2019n/an/a

-HK$5m

Mar 31 2019HK$10mHK$10m

-HK$13m

Dec 31 2018n/an/a

-HK$22m

Sep 30 2018n/an/a

-HK$32m

Jun 30 2018n/an/a

-HK$27m

Mar 31 2018HK$11mHK$11m

-HK$23m

Compensatie versus markt: De totale vergoeding ($USD 2.03M ) Joyce } ligt boven het gemiddelde voor bedrijven van vergelijkbare omvang in de Hong Kong markt ($USD 233.89K ).

Compensatie versus inkomsten: De vergoeding van Joyce is gestegen terwijl het bedrijf verliesgevend is.


CEO

Joyce Tsang (63 yo)

14.6yrs

Tenure

HK$15,785,000

Compensatie

Dr. Yue Tsang, also known as Joyce, is Founder of Modern Beauty Salon Holdings Limited (Modern Healthcare Technology Holdings Limited) and has been its Chairperson and Chief Executive Officer since April 1...


Leiderschapsteam

NaamPositieTenureCompensatieEigendom
Yue Tsang
Founder14.6yrsHK$15.79m74.88%
HK$ 62.3m
Kai Wing Yip
CTO & Executive Directorno dataHK$772.00k0.020%
HK$ 17.0k
See Man Yeung
Financial Controller & Executive Directorno dataHK$876.00k0.019%
HK$ 15.8k
Chi Ming Cheng
CFO & Company Secretary3.8yrsgeen gegevensgeen gegevens
Soo Ghee Lee
Chief Administrative Officer12.8yrsHK$2.01m0.072%
HK$ 59.8k
Hon Hui
Legal Counselno datageen gegevensgeen gegevens

12.8yrs

Gemiddelde duur

54yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van 919 is doorgewinterd en ervaren (gemiddelde ambtstermijn van 12.8 jaar).


Bestuursleden

NaamPositieTenureCompensatieEigendom
Yue Tsang
Founder14.6yrsHK$15.79m74.88%
HK$ 62.3m
Kai Wing Yip
CTO & Executive Director19.2yrsHK$772.00k0.020%
HK$ 17.0k
See Man Yeung
Financial Controller & Executive Director11.9yrsHK$876.00k0.019%
HK$ 15.8k
Man Hin Wong
Independent Non-Executive Director14.9yrsHK$264.00kgeen gegevens
Po Kui Hong
Independent Non-Executive Director14.9yrsHK$264.00kgeen gegevens
Mei Ling Liu
Independent Non-Executive Director14.9yrsHK$324.00kgeen gegevens
Tak Leung Lam
Independent Non-Executive Director1.1yrsHK$132.00kgeen gegevens

14.9yrs

Gemiddelde duur

62yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van 919 zijn ervaren en ervaren (gemiddelde ambtstermijn van 14.9 jaar).